Ligand Pharmaceuticals (LGND) EV to EBITDA (2011 - 2026)
Ligand Pharmaceuticals' (LGND) EV to EBITDA was 38.69 for Q2 2026, down 98.7% from 3031.87 a year earlier but up 53.6% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) EV to EBITDA (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ligand Pharmaceuticals' EV to EBITDA came in at 21.63, down 98.9% year-over-year; for FY2025, it came in at 40.19, down 71.7% from FY2024.
- By year, EV to EBITDA came in at 141.77 in FY2024 (+534.1%), 22.36 in FY2023 (+32.6%), 16.87 in FY2022 (+105.0%) and 8.23 in FY2021 (-11.3%).
- Five-year quarterly EV to EBITDA spans a low of 6.38 in Q1 2022 and a high of 3031.87 in Q2 2025.
- Year over year, EV to EBITDA gained in two of the last five quarters, with growth averaging 114.1%.
- The high point for year-over-year EV to EBITDA in five years was Q4 2024 (growth of 534.1%); the low point was Q2 2026 (a decline of 98.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 25.19 (Q1 2026), 40.19 (Q4 2025) and 54.48 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.18 Bn | 2.65 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.69 |
| Mar 31, 2026 | 25.19 |
| Dec 31, 2025 | 40.19 |
| Sep 30, 2025 | 54.48 |
| Jun 30, 2025 | 3,031.87 |
| Dec 31, 2024 | 141.77 |
| Sep 30, 2024 | 86.35 |
| Jun 30, 2024 | 69.24 |
| Mar 31, 2024 | 27.38 |
| Dec 31, 2023 | 22.36 |
| Sep 30, 2023 | 25.14 |
| Jun 30, 2023 | 21.47 |
| Mar 31, 2023 | 15.65 |
| Dec 31, 2022 | 16.87 |
| Sep 30, 2022 | 6.87 |
| Jun 30, 2022 | 6.77 |
| Mar 31, 2022 | 6.38 |
| Dec 31, 2021 | 8.23 |
| Sep 30, 2021 | 8.06 |
| Jun 30, 2021 | 8.85 |
API Access
Ligand Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();